[Cutaneous reactions induced by pegylated-interferon plus ribavirin combination therapy in a patient with chronic hepatitis C].
A 67 years old woman with chronic hepatitis C was treated with pegylated-interferon plus ribavirin combination therapy. Three weeks after starting the therapy, severe cutaneous adverse reaction occurred on her. Specific treatment successfully suppressed the symptom and pegylated-interferon plus ribavirin combination therapy was completely done. Cutaneous reactions induced by pegylated-interferon plus ribavirin combination therapy was reviewed.
Enjoji
Munechika
M
Department of Hepatology and Pancreatology, Kyushu University Hospital.
Dainichi
Teruki
T
Gondo
Hisaki
H
Urabe
Kazunori
K
D000368:Aged; D018926:Anti-Allergic Agents / Q000008:administration & dosage; D000998:Antiviral Agents / Q000009:adverse effects* / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005260:Female; D019698:Hepatitis C, Chronic / Q000188:drug therapy*; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000009:adverse effects* / Q000627:therapeutic use; D011092:Polyethylene Glycols; D011994:Recombinant Proteins; D012254:Ribavirin / Q000009:adverse effects* / Q000627:therapeutic use; D012871:Skin Diseases / Q000139:chemically induced* / Q000188:drug therapy
D018926:Anti-Allergic Agents; D000998:Antiviral Agents; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins; D011092:Polyethylene Glycols; D012254:Ribavirin; C417083:peginterferon alfa-2b